Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 14/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.37 |
| ▸ | KIF18A | Q8NI77 | 1/20 | 0.36 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4270026 | 0.96 | F10 (0.40) | F10IRAK4KIF18AIRAK1RXFP1 | |
| SCHEMBL4270700 | 0.94 | F10 (0.41) | F10IRAK4KIF18ARXFP1KDM4E | |
| SCHEMBL5724573 | 0.86 | F10 (0.38) | F10RXFP1KDM4E | |
| SCHEMBL4269020 | 0.86 | IRAK4 (0.49) | F10IRAK4IRAK1KDM4ENPC1 | |
| Hydrochloric Acid SCHEMBL4269636 | 0.85 | IRAK4 (0.49) | F10IRAK4IRAK1KDM4ENPC1 | |
| SCHEMBL5724434 | 0.85 | F10 (0.37) | F10IRAK4IRAK1RXFP1NPC1 | |
| SCHEMBL4269145 | 0.83 | F10 (0.45) | F10IRAK4IRAK1KDM4ENPC1 | |
| SCHEMBL4269132 | 0.83 | F10 (0.45) | F10IRAK4IRAK1KDM4ENPC1 | |
| SCHEMBL4277311 | 0.83 | F10 (0.45) | F10IRAK4IRAK1KDM4ENPC1 | |
| SCHEMBL5724779 | 0.83 | F10 (0.38) | F10KDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644334-A1 | ANTITHROMBOTIC ETHERS | Eli Lilly and Company (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2004108677-A1 | ANTITHROMBOTIC ETHERS | ELI LILLY AND COMPANY (US) | 2004-12-16 | — | — | WO | disclosed |